S&P 500   3,570.90 (+0.38%)
DOW   29,527.93 (+0.90%)
QQQ   290.05 (-0.11%)
AAPL   114.75 (-2.21%)
MSFT   209.74 (-0.31%)
FB   268.33 (-0.51%)
GOOGL   1,725.37 (-0.63%)
AMZN   3,103.10 (+0.12%)
TSLA   522.01 (+6.62%)
NVDA   525.81 (+0.44%)
BABA   270.32 (-0.16%)
CGC   24.77 (+4.43%)
GE   10.10 (+3.48%)
MU   63.96 (+4.17%)
AMD   85.39 (+0.89%)
T   28.53 (+0.74%)
NIO   53.70 (+9.04%)
F   8.88 (+1.60%)
ACB   7.27 (+1.96%)
GILD   59.42 (-1.15%)
NFLX   481.50 (-1.38%)
BA   209.29 (+4.84%)
DIS   146.12 (+3.58%)
S&P 500   3,570.90 (+0.38%)
DOW   29,527.93 (+0.90%)
QQQ   290.05 (-0.11%)
AAPL   114.75 (-2.21%)
MSFT   209.74 (-0.31%)
FB   268.33 (-0.51%)
GOOGL   1,725.37 (-0.63%)
AMZN   3,103.10 (+0.12%)
TSLA   522.01 (+6.62%)
NVDA   525.81 (+0.44%)
BABA   270.32 (-0.16%)
CGC   24.77 (+4.43%)
GE   10.10 (+3.48%)
MU   63.96 (+4.17%)
AMD   85.39 (+0.89%)
T   28.53 (+0.74%)
NIO   53.70 (+9.04%)
F   8.88 (+1.60%)
ACB   7.27 (+1.96%)
GILD   59.42 (-1.15%)
NFLX   481.50 (-1.38%)
BA   209.29 (+4.84%)
DIS   146.12 (+3.58%)
S&P 500   3,570.90 (+0.38%)
DOW   29,527.93 (+0.90%)
QQQ   290.05 (-0.11%)
AAPL   114.75 (-2.21%)
MSFT   209.74 (-0.31%)
FB   268.33 (-0.51%)
GOOGL   1,725.37 (-0.63%)
AMZN   3,103.10 (+0.12%)
TSLA   522.01 (+6.62%)
NVDA   525.81 (+0.44%)
BABA   270.32 (-0.16%)
CGC   24.77 (+4.43%)
GE   10.10 (+3.48%)
MU   63.96 (+4.17%)
AMD   85.39 (+0.89%)
T   28.53 (+0.74%)
NIO   53.70 (+9.04%)
F   8.88 (+1.60%)
ACB   7.27 (+1.96%)
GILD   59.42 (-1.15%)
NFLX   481.50 (-1.38%)
BA   209.29 (+4.84%)
DIS   146.12 (+3.58%)
S&P 500   3,570.90 (+0.38%)
DOW   29,527.93 (+0.90%)
QQQ   290.05 (-0.11%)
AAPL   114.75 (-2.21%)
MSFT   209.74 (-0.31%)
FB   268.33 (-0.51%)
GOOGL   1,725.37 (-0.63%)
AMZN   3,103.10 (+0.12%)
TSLA   522.01 (+6.62%)
NVDA   525.81 (+0.44%)
BABA   270.32 (-0.16%)
CGC   24.77 (+4.43%)
GE   10.10 (+3.48%)
MU   63.96 (+4.17%)
AMD   85.39 (+0.89%)
T   28.53 (+0.74%)
NIO   53.70 (+9.04%)
F   8.88 (+1.60%)
ACB   7.27 (+1.96%)
GILD   59.42 (-1.15%)
NFLX   481.50 (-1.38%)
BA   209.29 (+4.84%)
DIS   146.12 (+3.58%)
Log in
NASDAQ:AERI

Aerie Pharmaceuticals News Headlines

$12.38
+0.33 (+2.74 %)
(As of 11/23/2020 01:41 PM ET)
Add
Compare
Today's Range
$12.01
Now: $12.38
$12.59
50-Day Range
$9.12
MA: $11.38
$13.05
52-Week Range
$9.01
Now: $12.38
$26.26
Volume15,237 shs
Average Volume862,954 shs
Market Capitalization$579.57 million
P/E RatioN/A
Dividend YieldN/A
Beta0.7

Headlines

Aerie Pharmaceuticals (NASDAQ AERI) News Headlines Today

Source:
SourceHeadline
HC Wainwright Lowers Aerie Pharmaceuticals (NASDAQ:AERI) Price Target to $29.00HC Wainwright Lowers Aerie Pharmaceuticals (NASDAQ:AERI) Price Target to $29.00
marketbeat.com - November 9 at 7:56 AM
BidaskClub Upgrades Aerie Pharmaceuticals (NASDAQ:AERI) to "Hold"BidaskClub Upgrades Aerie Pharmaceuticals (NASDAQ:AERI) to "Hold"
marketbeat.com - October 29 at 4:12 AM
Raymond James Reiterates Hold Rating for Aerie Pharmaceuticals (NASDAQ:AERI)Raymond James Reiterates Hold Rating for Aerie Pharmaceuticals (NASDAQ:AERI)
marketbeat.com - September 28 at 6:09 PM
BidaskClub Lowers Aerie Pharmaceuticals (NASDAQ:AERI) to Strong SellBidaskClub Lowers Aerie Pharmaceuticals (NASDAQ:AERI) to Strong Sell
marketbeat.com - August 27 at 2:15 AM
Aerie Pharmaceuticals (NASDAQ:AERI) Now Covered by Analysts at Needham & Company LLCAerie Pharmaceuticals (NASDAQ:AERI) Now Covered by Analysts at Needham & Company LLC
marketbeat.com - August 15 at 3:10 AM
European advisory group backs Aerie Pharmas RoclandaEuropean advisory group backs Aerie Pharma's Roclanda
seekingalpha.com - November 13 at 5:39 PM
Insider Selling: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) Insider Sells 7,305 Shares of StockInsider Selling: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) Insider Sells 7,305 Shares of Stock
americanbankingnews.com - November 12 at 5:57 PM
Aerie Pharmaceuticals (NASDAQ:AERI) Announces  Earnings Results, Beats Estimates By $0.16 EPSAerie Pharmaceuticals (NASDAQ:AERI) Announces Earnings Results, Beats Estimates By $0.16 EPS
americanbankingnews.com - November 10 at 12:31 PM
HC Wainwright & Co. Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $29HC Wainwright & Co. Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $29
benzinga.com - November 10 at 10:07 AM
Aerie Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare ConferenceAerie Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare Conference
finance.yahoo.com - November 10 at 10:07 AM
Aerie Pharmaceuticals (NASDAQ:AERI) Shares Up 17.2%Aerie Pharmaceuticals (NASDAQ:AERI) Shares Up 17.2%
americanbankingnews.com - November 9 at 9:42 PM
HC Wainwright Trims Aerie Pharmaceuticals (NASDAQ:AERI) Target Price to $29.00HC Wainwright Trims Aerie Pharmaceuticals (NASDAQ:AERI) Target Price to $29.00
americanbankingnews.com - November 9 at 10:35 AM
Aerie Pharmaceuticals (AERI) CEO Vince Anido on Q3 2020 Results - Earnings Call TranscriptAerie Pharmaceuticals' (AERI) CEO Vince Anido on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 3:44 AM
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) Just Released Its Third-Quarter Earnings: Heres What Analysts ThinkAerie Pharmaceuticals, Inc. (NASDAQ:AERI) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
nasdaq.com - November 7 at 12:08 PM
Aerie Pharmaceuticals Inc (AERI) Q3 2020 Earnings Call TranscriptAerie Pharmaceuticals Inc (AERI) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 7 at 7:07 AM
Why the pandemic has this Durham drugmaker missing out on global salesWhy the pandemic has this Durham drugmaker missing out on global sales
bizjournals.com - November 6 at 3:36 PM
Aerie (AERI) Q3 Loss Narrower Than Expected, Sales Rise Y/YAerie (AERI) Q3 Loss Narrower Than Expected, Sales Rise Y/Y
finance.yahoo.com - November 6 at 3:36 PM
Aerie Pharmaceuticals, Inc. (AERI) CEO Vicente Anido On Q3 2020 Results - Quick Version Earnings Call TranscriptAerie Pharmaceuticals, Inc. (AERI) CEO Vicente Anido On Q3 2020 Results - Quick Version Earnings Call Transcript
seekingalpha.com - November 5 at 10:32 PM
Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue EstimatesAerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 5 at 10:31 PM
Aerie Pharmaceuticals EPS beats by $0.15, beats on revenueAerie Pharmaceuticals EPS beats by $0.15, beats on revenue
seekingalpha.com - November 5 at 5:31 PM
Aerie Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business UpdateAerie Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - November 5 at 5:31 PM
-$0.81 EPS Expected for Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) This Quarter-$0.81 EPS Expected for Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) This Quarter
americanbankingnews.com - November 2 at 11:16 PM
Heat Biologics Provides Update, And Other News: The Good, Bad And Ugly Of BiopharmaHeat Biologics Provides Update, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - November 2 at 7:03 AM
Critical Survey: Aerie Pharmaceuticals (NASDAQ:AERI) and Adaptimmune Therapeutics (NASDAQ:ADAP)Critical Survey: Aerie Pharmaceuticals (NASDAQ:AERI) and Adaptimmune Therapeutics (NASDAQ:ADAP)
americanbankingnews.com - November 1 at 7:12 AM
Aerie Pharma launches mid-stage study with AR-15512 in dry eye diseaseAerie Pharma launches mid-stage study with AR-15512 in dry eye disease
seekingalpha.com - October 29 at 8:21 AM
Aerie Pharmaceuticals Initiates Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for the Treatment of Patients with Dry Eye DiseaseAerie Pharmaceuticals Initiates Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for the Treatment of Patients with Dry Eye Disease
finance.yahoo.com - October 29 at 8:21 AM
Aerie Pharmaceuticals' (NASDAQ:AERI) Stock Price Has Reduced 85% In The Past Three YearsAerie Pharmaceuticals' (NASDAQ:AERI) Stock Price Has Reduced 85% In The Past Three Years
finance.yahoo.com - October 20 at 9:23 AM
Why Aerie Pharmaceuticals Is Trading Lower TodayWhy Aerie Pharmaceuticals Is Trading Lower Today
benzinga.com - October 19 at 6:29 PM
Durham drugmaker cleared to start clinical testing with treatment for dry eyeDurham drugmaker cleared to start clinical testing with treatment for dry eye
bizjournals.com - September 29 at 4:13 PM
Aerie Pharma on go with mid-stage study of eye drop for dry eyeAerie Pharma on go with mid-stage study of eye drop for dry eye
seekingalpha.com - September 29 at 11:13 AM
Why a Durham drugmaker says new data boosts its European effortsWhy a Durham drugmaker says new data boosts its European efforts
bizjournals.com - September 25 at 8:36 AM
Antiglaucoma Drugs Global Market Report 2020-30: Covid 19 Impact and RecoveryAntiglaucoma Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
marketwatch.com - September 24 at 6:32 PM
Aerie says Roclanda non-inferior to Ganfort in late-stage glaucoma study in EuropeAerie says Roclanda 'non-inferior' to Ganfort in late-stage glaucoma study in Europe
seekingalpha.com - September 24 at 8:31 AM
Aerie Pharmaceuticals Announces Successful Interim 90-Day Topline Data From Its Six-Month Mercury 3 Clinical Trial in EuropeAerie Pharmaceuticals Announces Successful Interim 90-Day Topline Data From Its Six-Month Mercury 3 Clinical Trial in Europe
finance.yahoo.com - September 24 at 8:31 AM
FDA OKs Aerie Pharmas Rhopressa production facility in IrelandFDA OKs Aerie Pharma's Rhopressa production facility in Ireland
seekingalpha.com - September 15 at 8:25 AM
Aerie Pharmaceuticals Announces U.S. Food and Drug Administration Approval of its Athlone, Ireland Facility for Production of Rhopressa® (netarsudil ophthalmic solution) 0.02%Aerie Pharmaceuticals Announces U.S. Food and Drug Administration Approval of its Athlone, Ireland Facility for Production of Rhopressa® (netarsudil ophthalmic solution) 0.02%
finance.yahoo.com - September 15 at 8:25 AM
GW Pharmaceuticals Announces the Appointment of David Gryska to its Board of DirectorsGW Pharmaceuticals Announces the Appointment of David Gryska to its Board of Directors
marketwatch.com - September 10 at 8:34 AM
American Eagle Outfitters Promotes Aerie Global Brand President Jennifer Foyle to Chief Creative OfficerAmerican Eagle Outfitters Promotes Aerie Global Brand President Jennifer Foyle to Chief Creative Officer
finance.yahoo.com - September 9 at 8:00 AM
Aerie initiated Buy at GuggenheimAerie initiated Buy at Guggenheim
seekingalpha.com - September 8 at 4:58 PM
Aerie Pharmaceuticals to Participate in Upcoming Virtual Investor ConferencesAerie Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
finance.yahoo.com - September 8 at 11:58 AM
Why Is Aerie (AERI) Down 3.6% Since Last Earnings Report?Why Is Aerie (AERI) Down 3.6% Since Last Earnings Report?
finance.yahoo.com - September 5 at 1:15 PM
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI): When Will It Breakeven?Aerie Pharmaceuticals, Inc. (NASDAQ:AERI): When Will It Breakeven?
finance.yahoo.com - August 21 at 2:12 PM
Ophthalmic Drugs Market In-depth Analysis, Reviews and Study Report 2020-2025Ophthalmic Drugs Market In-depth Analysis, Reviews and Study Report 2020-2025
marketwatch.com - August 21 at 8:43 AM
Aerie Pharmaceuticals, Inc. (AERI) CEO Vicente Anido on Q2 2020 Results - Earnings Call TranscriptAerie Pharmaceuticals, Inc. (AERI) CEO Vicente Anido on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 1:33 PM
Aerie Pharmaceuticals Inc (AERI) Q2 2020 Earnings Call TranscriptAerie Pharmaceuticals Inc (AERI) Q2 2020 Earnings Call Transcript
fool.com - August 8 at 10:27 AM
Aerie Pharmaceuticals EPS misses by $0.03, beats on revenueAerie Pharmaceuticals EPS misses by $0.03, beats on revenue
seekingalpha.com - August 6 at 6:37 PM
Aerie Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business UpdateAerie Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - August 6 at 6:37 PM
Aerie Pharmaceuticals to Announce Second Quarter 2020 Financial Results and Host Conference Call on Thursday, August 6, 2020Aerie Pharmaceuticals to Announce Second Quarter 2020 Financial Results and Host Conference Call on Thursday, August 6, 2020
finance.yahoo.com - July 30 at 10:12 AM
Will Aerie Pharmaceuticals (AERI) Report Negative Q2 Earnings? What You Should KnowWill Aerie Pharmaceuticals (AERI) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - July 29 at 1:31 PM
Aerie Pharma steroid implant shows treatment benefit in macular edema studyAerie Pharma steroid implant shows treatment benefit in macular edema study
seekingalpha.com - July 27 at 8:01 AM
Did Hedge Funds Make The Right Call On Aerie Pharmaceuticals Inc (AERI)Did Hedge Funds Make The Right Call On Aerie Pharmaceuticals Inc (AERI)
finance.yahoo.com - July 17 at 5:49 PM
Did Hedge Funds Make The Right Call On Aerie Pharmaceuticals Inc (AERI) ?Did Hedge Funds Make The Right Call On Aerie Pharmaceuticals Inc (AERI) ?
finance.yahoo.com - July 17 at 5:49 PM
Nystagmus Market 2020 Top Manufacturers, Latest Trends, Business Gross Margin, Growth Factor, Product Demand Industry Share and Forecast to 2025Nystagmus Market 2020 Top Manufacturers, Latest Trends, Business Gross Margin, Growth Factor, Product Demand Industry Share and Forecast to 2025
www.marketwatch.com - July 3 at 10:01 AM
Hedge Funds Are Buying Eagle Pharmaceuticals Inc (EGRX)Hedge Funds Are Buying Eagle Pharmaceuticals Inc (EGRX)
finance.yahoo.com - June 27 at 11:30 PM
Aerie Pharmaceuticals Inc (AERI): Hedge Funds Are NibblingAerie Pharmaceuticals Inc (AERI): Hedge Funds Are Nibbling
finance.yahoo.com - June 15 at 10:35 PM
This page was last updated on 11/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.